scispace - formally typeset
R

Raffaella Bonecchi

Researcher at Humanitas University

Publications -  99
Citations -  9168

Raffaella Bonecchi is an academic researcher from Humanitas University. The author has contributed to research in topics: Chemokine receptor & CCR1. The author has an hindex of 36, co-authored 94 publications receiving 8121 citations. Previous affiliations of Raffaella Bonecchi include Mario Negri Institute for Pharmacological Research & University of Brescia.

Papers
More filters
Journal ArticleDOI

Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

TL;DR: T helper cells type 1 (Th1s) that produce interferon-γ predominantly mediate cellular immune responses and are involved in the development of chronic inflammatory conditions, whereas Th2s which produce large amounts of IL-4 and IL-5 upregulate IgE production and are prominent in the pathogenesis of allergic diseases.
Journal Article

Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties.

TL;DR: Concomitantly, the expression of CCR7 and the migration to its ligand EBI1 ligand chemokine (ELC)/macrophage inflammatory protein (MIP)-3beta, a chemokines expressed in lymphoid organs, were strongly up-regulated, though with slower kinetics (24-48 h).
Journal Article

Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells

TL;DR: Analysis of polarized subsets of CD8+ T cells reveals a similar pattern of chemokine receptor expression and modulation of responsiveness, suggesting that an up-regulation of CCR4 and CCR8 following Ag encounter may contribute to the proper positioning of activated T cells within sites of antigenic challenge and/or specialized areas of lymphoid tissues.
Journal ArticleDOI

Tuning inflammation and immunity by chemokine sequestration: decoys and more

TL;DR: A set of chemokine receptors are structurally unable to elicit migration or conventional signalling responses after ligand engagement, and therefore represent a general strategy to tune, shape and temper innate and adaptive immunity.
Journal ArticleDOI

Neutrophil diversity and plasticity in tumour progression and therapy.

TL;DR: The emerging dual role played by neutrophils in the tumour microenvironment is discussed, while also mediating antitumour immune responses, and it is suggested that neutrophil function could be manipulated in myeloid cell-based therapeutic approaches to improve patient outcomes.